{"id":"dha-docosahexaenoic-acid","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Fish odor/aftertaste"},{"rate":null,"effect":"Bleeding or bruising (at high doses)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"DHA (docosahexaenoic acid) is a 22-carbon omega-3 fatty acid that comprises a significant portion of neuronal cell membranes, particularly in the cerebral cortex and retina. It is hypothesized to reduce cognitive decline in Alzheimer's disease by maintaining synaptic plasticity, reducing amyloid-beta accumulation, and decreasing neuroinflammatory markers. DHA may also enhance mitochondrial function and promote neuroprotection through anti-inflammatory and antioxidant mechanisms.","oneSentence":"DHA is an omega-3 polyunsaturated fatty acid that supports neuronal membrane integrity and reduces neuroinflammation in the brain.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:45:51.999Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mild to moderate Alzheimer's disease (cognitive decline prevention)"}]},"trialDetails":[{"nctId":"NCT07496515","phase":"PHASE2","title":"Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia","status":"NOT_YET_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2026-06-01","conditions":"Pediatric Chalazia","enrollment":168},{"nctId":"NCT05297279","phase":"NA","title":"OMEGA - Dietary Intervention - COPD Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-01","conditions":"COPD, Chronic Obstructive Pulmonary Disease","enrollment":200},{"nctId":"NCT04485871","phase":"NA","title":"Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids","status":"RECRUITING","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2019-12-19","conditions":"Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance","enrollment":48},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT06975241","phase":"PHASE4","title":"Observing Metabolism of EPA With Consideration of Genetics And Sex","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-07-29","conditions":"Healthy, Omega 3, Metabolism, Lipids","enrollment":64},{"nctId":"NCT00682318","phase":"NA","title":"Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carsten Skarke, MD","startDate":"2008-05","conditions":"Healthy","enrollment":40},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT05995717","phase":"NA","title":"Evaluation of PKU UP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vitaflo International, Ltd","startDate":"2024-01-11","conditions":"PKU","enrollment":16},{"nctId":"NCT05774665","phase":"PHASE2","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-30","conditions":"Treatment Resistant Depression, Inflammation, Overweight","enrollment":80},{"nctId":"NCT06711614","phase":"NA","title":"FIRE-Diet: Food as an Intervention to Reduce the Effects of Woodsmoke Exposure on Respiratory Health","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-06-17","conditions":"Healthy Individuals","enrollment":48},{"nctId":"NCT07394517","phase":"NA","title":"ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3","status":"NOT_YET_RECRUITING","sponsor":"Fundación del Caribe para la Investigación Biomédica","startDate":"2026-03","conditions":"Mixed Dyslipidemia","enrollment":105},{"nctId":"NCT01747447","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2012-08","conditions":"Bone Density, Body Composition, Bone Health","enrollment":771},{"nctId":"NCT07392723","phase":"PHASE2","title":"ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults","status":"RECRUITING","sponsor":"Michal Schnaider Beeri, Ph.D.","startDate":"2025-01-12","conditions":"Cognitive Dysfunction, Alzheimer Disease, Blood-Brain Barrier","enrollment":20},{"nctId":"NCT07004777","phase":"NA","title":"Effect of Consuming n-3 PUFAs Rich Foods on Triglyceride Concentration and Lipoprotein Composition","status":"RECRUITING","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2026-02-01","conditions":"Hypertriglyceridemia","enrollment":375},{"nctId":"NCT01704859","phase":"NA","title":"VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2018-06-01","conditions":"Fractures","enrollment":25871},{"nctId":"NCT04573946","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2019-07-01","conditions":"Bone Density, Bone Health, Fractures","enrollment":25871},{"nctId":"NCT07365553","phase":"NA","title":"Omega-3, Autism Spectrum Disorder (ASD)","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2022-07-15","conditions":"ASD","enrollment":50},{"nctId":"NCT07364331","phase":"NA","title":"Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2021-09-04","conditions":"ADHD, Children, Adolescents","enrollment":100},{"nctId":"NCT07042009","phase":"NA","title":"Effectiveness of Nutritional Resources for Milk Donors","status":"NOT_YET_RECRUITING","sponsor":"University of Roehampton","startDate":"2026-02-02","conditions":"Docosahexaenoic Acid Content of the Participants, Docosahexaenoic Acid Content of the Breast Milk","enrollment":60},{"nctId":"NCT07346703","phase":"NA","title":"Effects of DHA in Patients With Multiple Sclerosis","status":"ENROLLING_BY_INVITATION","sponsor":"Francisco Javier Martínez Noguera","startDate":"2026-01","conditions":"Multiple Sclerosis, Performance Enhancement, Supplemental Nutrition Assistance Program Education","enrollment":100},{"nctId":"NCT07348562","phase":"NA","title":"Omega-3, Inflammation in ADHD With AI","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2021-02-01","conditions":"Adhd","enrollment":15},{"nctId":"NCT07322965","phase":"NA","title":"Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma","status":"RECRUITING","sponsor":"Institut Catala de Retina","startDate":"2025-04-01","conditions":"Glaucoma, Primary Open Angle Glaucoma (POAG), Neuroprotection","enrollment":108},{"nctId":"NCT06331195","phase":"NA","title":"An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2024-10-23","conditions":"Familial Hypercholesterolemia","enrollment":300},{"nctId":"NCT05695937","phase":"NA","title":"Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Patients With Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Hospital do Coracao","startDate":"2023-05-22","conditions":"Familial Hypercholesterolemia","enrollment":58},{"nctId":"NCT02168738","phase":"NA","title":"Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-03","conditions":"Healthy Subject","enrollment":4},{"nctId":"NCT01653678","phase":"NA","title":"Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2011-11","conditions":"Hypertension","enrollment":25875},{"nctId":"NCT06695910","phase":"PHASE4","title":"Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","status":"RECRUITING","sponsor":"Samuel Fortin","startDate":"2024-11-06","conditions":"Brain Fog, Cognitive Health","enrollment":48},{"nctId":"NCT01696435","phase":"NA","title":"VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Depression, Depressive Symptoms, Mood","enrollment":18353},{"nctId":"NCT04499820","phase":"NA","title":"Effect of OMEGA3 Supplementation in Diabetic Retinopathy","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2020-06-26","conditions":"Diabetic Retinopathy","enrollment":60},{"nctId":"NCT01351805","phase":"NA","title":"Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Autoimmune Diseases, Systemic Inflammatory Process, Knee Pain Chronic","enrollment":25871},{"nctId":"NCT04761588","phase":"NA","title":"Evaluation of TYR Sphere in France","status":"COMPLETED","sponsor":"Vitaflo International, Ltd","startDate":"2021-12-01","conditions":"Tyrosinemia, AKU","enrollment":14},{"nctId":"NCT01632761","phase":"NA","title":"Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-11","conditions":"Anemia","enrollment":2000},{"nctId":"NCT06233825","phase":"NA","title":"Nutritional Intervention to Enhance Recovery After Arthroscopic Knee Surgery in Adults","status":"COMPLETED","sponsor":"Dr. Chris McGlory, PhD","startDate":"2024-02-01","conditions":"Anterior Cruciate Ligament Reconstruction, Muscular Atrophy","enrollment":30},{"nctId":"NCT04312932","phase":"PHASE2","title":"Fatty Acid Supplementation in Children With ASD (Study 2)","status":"COMPLETED","sponsor":"Sarah Keim","startDate":"2021-12-01","conditions":"Autism Spectrum Disorder","enrollment":98},{"nctId":"NCT04417257","phase":"PHASE2, PHASE3","title":"Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults","status":"TERMINATED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2020-08-18","conditions":"COVID-19 Disease","enrollment":351},{"nctId":"NCT01169259","phase":"PHASE3","title":"Vitamin D and Omega-3 Trial (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Cancer, Cardiovascular Disease","enrollment":25871},{"nctId":"NCT00244816","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Eye Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":22},{"nctId":"NCT00422877","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2007-01","conditions":"Cancer of the Liver","enrollment":13},{"nctId":"NCT02178410","phase":"PHASE3","title":"VITAL Rhythm Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-10","conditions":"Cardiovascular Disease","enrollment":25119},{"nctId":"NCT06294067","phase":"PHASE1","title":"A Dose Response Investigation of Docosahexaenoic Acid (DHA)","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2024-02-26","conditions":"Nutrition, Healthy","enrollment":72},{"nctId":"NCT06494488","phase":"EARLY_PHASE1","title":"Differential Thrombogenesis by EPA and DHA Mediated by HDL","status":"RECRUITING","sponsor":"The Miriam Hospital","startDate":"2025-07-10","conditions":"Lipid Metabolism Disorders, Hypertriglyceridemia","enrollment":80},{"nctId":"NCT01624792","phase":"NA","title":"Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2011-10-25","conditions":"Chronic Obstructive Pulmonary Disease, Muscle Wasting","enrollment":64},{"nctId":"NCT00249262","phase":"PHASE2","title":"Taxoprexin Treatment for Advanced Skin Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":30},{"nctId":"NCT01758081","phase":"NA","title":"Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)","enrollment":25874},{"nctId":"NCT05380401","phase":"NA","title":"Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2023-03-09","conditions":"Premature","enrollment":328},{"nctId":"NCT02295059","phase":"NA","title":"Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2017-08-09","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT01178398","phase":"","title":"Understanding Fish Consumption Habits During Pregnancy","status":"COMPLETED","sponsor":"Harvard Pilgrim Health Care","startDate":"2009-10","conditions":"Nutrition","enrollment":22},{"nctId":"NCT07173881","phase":"NA","title":"Effect of a Dairy Product for Pregnant and Lactating Women on the Composition of Human Milk","status":"RECRUITING","sponsor":"Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri","startDate":"2025-08-01","conditions":"Pregnancy","enrollment":20},{"nctId":"NCT05007483","phase":"NA","title":"Efficacy of Diet on Quality of Life in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terry L. Wahls","startDate":"2022-02-10","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":162},{"nctId":"NCT05297383","phase":"NA","title":"Combining HIIT and n-3 PUFA Supplementation to Reduce Inflammation and Improve Metabolic Health (HIIT&PUFA)","status":"WITHDRAWN","sponsor":"Texas Tech University","startDate":"2022-04-01","conditions":"Obesity, Inflammation, Insulin Resistance","enrollment":""},{"nctId":"NCT05295719","phase":"NA","title":"Combining HIIT and n-3 PUFA to Reduce Inflammation and Improve Metabolic Health","status":"COMPLETED","sponsor":"Texas Tech University","startDate":"2022-09-01","conditions":"Obesity, Inflammation, Human Microbiome","enrollment":129},{"nctId":"NCT06971445","phase":"NA","title":"Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","startDate":"2025-05-14","conditions":"Pregnant HIV Positive Women","enrollment":92},{"nctId":"NCT05802797","phase":"EARLY_PHASE1","title":"Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-04-03","conditions":"Healthy Diet","enrollment":24},{"nctId":"NCT07134140","phase":"NA","title":"Omega-3 Fatty Acids in Muscle Function and Health","status":"NOT_YET_RECRUITING","sponsor":"European University Cyprus","startDate":"2025-09","conditions":"Healthy","enrollment":32},{"nctId":"NCT04076176","phase":"NA","title":"The Effects of CGMP in Children and Adults With PKU","status":"COMPLETED","sponsor":"Vitaflo International, Ltd","startDate":"2019-04-26","conditions":"Phenylketonurias","enrollment":12},{"nctId":"NCT07118059","phase":"PHASE2","title":"Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial","status":"NOT_YET_RECRUITING","sponsor":"North-West University, South Africa","startDate":"2025-08","conditions":"Tuberculosis, Inflammation Biomarkers, Liver Function Tests","enrollment":40},{"nctId":"NCT07117903","phase":"NA","title":"Zhongshan Ketogenic Diet Study 1","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-10","conditions":"Platelet Function and Thrombus Formation","enrollment":80},{"nctId":"NCT01442480","phase":"NA","title":"Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles","status":"COMPLETED","sponsor":"Environmental Protection Agency (EPA)","startDate":"2009-06","conditions":"Healthy","enrollment":29},{"nctId":"NCT02348073","phase":"PHASE3","title":"Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-03","conditions":"Attention Deficit Disorder With Hyperactivity, ADHD Inattention or Mixed Type, Epilepsy","enrollment":77},{"nctId":"NCT00243867","phase":"PHASE3","title":"Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-11","conditions":"Non-Small Cell Lung Cancer","enrollment":518},{"nctId":"NCT05673070","phase":"NA","title":"Use of Ritual Prenatal Multivitamins for Pregnancy","status":"COMPLETED","sponsor":"City University of New York","startDate":"2023-10-15","conditions":"Pregnancy Related, Nutrition, Healthy","enrollment":62},{"nctId":"NCT00087776","phase":"PHASE3","title":"Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2002-12-06","conditions":"Malignant Melanoma","enrollment":393},{"nctId":"NCT05915806","phase":"NA","title":"Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2023-07-30","conditions":"Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions","enrollment":1801},{"nctId":"NCT03831178","phase":"PHASE2","title":"Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting","status":"ACTIVE_NOT_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2019-08-28","conditions":"Breast Cancer","enrollment":76},{"nctId":"NCT07013981","phase":"NA","title":"The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial","status":"COMPLETED","sponsor":"National Science and Technology Council, Taiwan","startDate":"2013-01-09","conditions":"Depressive Symptoms","enrollment":5},{"nctId":"NCT06881966","phase":"NA","title":"The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Hopital Charles Nicolle","startDate":"2025-09-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":180},{"nctId":"NCT04222660","phase":"NA","title":"Corneal Nerves Function and Structure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-06-21","conditions":"Diabetic Peripheral Neuropathy","enrollment":44},{"nctId":"NCT06738446","phase":"NA","title":"Dietary Supplementation on Tear Secretion and Inflammation in DES","status":"COMPLETED","sponsor":"Shih Chien Huang","startDate":"2021-09-27","conditions":"Dry Eye Syndrome (DES)","enrollment":52},{"nctId":"NCT05191823","phase":"NA","title":"Omega Tots Long Term Follow-up","status":"ENROLLING_BY_INVITATION","sponsor":"Sarah Keim","startDate":"2021-12-01","conditions":"Preterm Birth, Child Development","enrollment":377},{"nctId":"NCT04796207","phase":"NA","title":"The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2019-05-28","conditions":"Traumatic Brain Injury (TBI), Chronic Traumatic Encephalopathy (CTE)","enrollment":38},{"nctId":"NCT02647723","phase":"NA","title":"Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2016-01","conditions":"Pregnancy, Child Development","enrollment":168},{"nctId":"NCT06928701","phase":"NA","title":"Impact of \"Targeted\" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)","status":"RECRUITING","sponsor":"University of Eastern Piedmont","startDate":"2024-09-01","conditions":"Early Breast Cancer, Neoadjuvant Treatment","enrollment":160},{"nctId":"NCT05573672","phase":"PHASE2","title":"Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2022-08-12","conditions":"Generalized Anxiety Disorder","enrollment":50},{"nctId":"NCT02521753","phase":"NA","title":"Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients","status":"TERMINATED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2015-08","conditions":"Polycystic Ovary Syndrome, Obesity","enrollment":123},{"nctId":"NCT05953064","phase":"NA","title":"Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2023-01-01","conditions":"Hypertriglyceridemia","enrollment":20},{"nctId":"NCT05621083","phase":"NA","title":"Omega-3 Fatty Acids on Fasting and Postprandial Triglycerides (TG) Response - a Pilot Study","status":"COMPLETED","sponsor":"University of Oslo","startDate":"2023-04-11","conditions":"Healthy","enrollment":34},{"nctId":"NCT06154408","phase":"NA","title":"Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2022-02-10","conditions":"LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease","enrollment":102},{"nctId":"NCT03216057","phase":"NA","title":"Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.","status":"COMPLETED","sponsor":"Hospital Infantil de Mexico Federico Gomez","startDate":"2008-05-20","conditions":"Hypertriglyceridemia, Pediatric Obesity","enrollment":168},{"nctId":"NCT03313076","phase":"PHASE2","title":"Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-07-19","conditions":"Chronic Pain Following Thermal Burn Injury","enrollment":24},{"nctId":"NCT03838536","phase":"NA","title":"Synergistic Activity of Human Milk Nutrients and Infant Cognition","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-02-05","conditions":"Breastfeeding, Exclusive","enrollment":84},{"nctId":"NCT06555705","phase":"NA","title":"Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-04-03","conditions":"Obesity, Childhood","enrollment":60},{"nctId":"NCT05841927","phase":"NA","title":"Clinical Cohort Study of DHA in Neurodevelopmental Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2020-12-01","conditions":"Autism or Autistic Traits","enrollment":40},{"nctId":"NCT04496154","phase":"NA","title":"Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry \"Bad Cholesterol\" in the Blood","status":"COMPLETED","sponsor":"May Faraj, PDt, PhD","startDate":"2013-09-05","conditions":"Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response","enrollment":41},{"nctId":"NCT01728571","phase":"NA","title":"LungVITamin D and OmegA-3 Trial (lungVITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"COPD, Asthma, Pulmonary Function","enrollment":25871},{"nctId":"NCT05971147","phase":"NA","title":"Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation","status":"COMPLETED","sponsor":"Dr. Chris McGlory, PhD","startDate":"2023-08-01","conditions":"Skeletal Muscle Fatty Acid Metabolism","enrollment":29},{"nctId":"NCT06781918","phase":"PHASE3","title":"Severe Acute Malnutrition and Child Development Clinical Trial in Mwanza","status":"NOT_YET_RECRUITING","sponsor":"National Institute for Medical Research, Tanzania","startDate":"2025-02-03","conditions":"Severe Acute Malnutrition in Childhood","enrollment":800},{"nctId":"NCT05015348","phase":"NA","title":"Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2021-12-01","conditions":"Hyperlipidemias","enrollment":120},{"nctId":"NCT03576989","phase":"NA","title":"Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2019-04-15","conditions":"Chronic Venous Leg Ulcers","enrollment":296},{"nctId":"NCT06302023","phase":"PHASE2","title":"Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2024-04-01","conditions":"Pregnant Women Diagnosed With Threatened Preterm Labor","enrollment":60},{"nctId":"NCT04531410","phase":"NA","title":"NETwork of Linoleic Acid Supplementation in Cystic Fibrosis","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2021-10-25","conditions":"Cystic Fibrosis","enrollment":50},{"nctId":"NCT05207059","phase":"NA","title":"Healthy Early Life Moments in Singapore","status":"RECRUITING","sponsor":"KK Women's and Children's Hospital","startDate":"2022-03-18","conditions":"Metabolic Disease, Mental Health Wellness 1, Lifestyle Risk Reduction","enrollment":500},{"nctId":"NCT03265288","phase":"PHASE2","title":"Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults","status":"COMPLETED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2018-11-05","conditions":"Cystic Fibrosis","enrollment":166},{"nctId":"NCT03310983","phase":"","title":"Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2017-11-01","conditions":"Pregnancy; Nutritional Diseases","enrollment":254},{"nctId":"NCT03808519","phase":"NA","title":"n3 PUFA and Muscle-disuse Atrophy in Older Women","status":"TERMINATED","sponsor":"McMaster University","startDate":"2019-02-18","conditions":"Muscle Atrophy, Muscle Disuse Atrophy, Sarcopenia","enrollment":8},{"nctId":"NCT06319079","phase":"NA","title":"Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition","status":"RECRUITING","sponsor":"Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri","startDate":"2024-06-01","conditions":"Lactating Mothers, Infants","enrollment":120},{"nctId":"NCT05121766","phase":"PHASE1","title":"Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers","status":"TERMINATED","sponsor":"Hackensack Meridian Health","startDate":"2022-01-10","conditions":"COVID-19","enrollment":32},{"nctId":"NCT06074250","phase":"PHASE2, PHASE3","title":"Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome","status":"RECRUITING","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2024-08-15","conditions":"Perinatal Depression, PerinatalAnxiety","enrollment":100},{"nctId":"NCT06128694","phase":"PHASE3","title":"Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients","status":"UNKNOWN","sponsor":"Kalbe International Pte. Ltd","startDate":"2023-08-01","conditions":"Malnutrition; Protein, Cancer, Lung, Cancer Cervix","enrollment":108},{"nctId":"NCT06494566","phase":"EARLY_PHASE1","title":"Omega-3 Supplementation After Surgical Treatment of Obesity","status":"COMPLETED","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","startDate":"2019-04-10","conditions":"Obesity","enrollment":150},{"nctId":"NCT03613844","phase":"PHASE2","title":"DHA Brain Delivery Trial","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2018-09-01","conditions":"Brain DHA Delivery and Alzheimer's Disease Risk","enrollment":365}],"_emaApprovals":[],"_faersSignals":[{"count":6,"reaction":"OFF LABEL USE"},{"count":5,"reaction":"DYSPNOEA"},{"count":5,"reaction":"FATIGUE"},{"count":4,"reaction":"GASTROOESOPHAGEAL REFLUX DISEASE"},{"count":3,"reaction":"ARTHRALGIA"},{"count":3,"reaction":"CONDITION AGGRAVATED"},{"count":3,"reaction":"COVID-19"},{"count":3,"reaction":"DEATH"},{"count":3,"reaction":"DIARRHOEA"},{"count":3,"reaction":"INTENTIONAL PRODUCT USE ISSUE"}],"_approvalHistory":[],"publicationCount":173,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Neuromins"],"phase":"phase_3","status":"active","brandName":"DHA (Docosahexaenoic Acid)","genericName":"DHA (Docosahexaenoic Acid)","companyName":"Alzheimer's Disease Cooperative Study (ADCS)","companyId":"alzheimer-s-disease-cooperative-study-adcs","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DHA is an omega-3 polyunsaturated fatty acid that supports neuronal membrane integrity and reduces neuroinflammation in the brain. Used for Mild to moderate Alzheimer's disease (cognitive decline prevention).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}